Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.600
-0.020 (-0.76%)
Jul 25, 2025, 5:29 PM CET

STO:NEWBRY Ratios and Metrics

Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '25 Aug '24 Aug '23 Aug '22 Aug '21
79807887-
Market Cap Growth
-5.31%2.52%-9.92%--
Enterprise Value
67656548-
Last Close Price
2.603.304.004.44-
PS Ratio
1.692.177.6115.72-
PB Ratio
1.481.541.581.26-
P/TBV Ratio
12.3615.9521.124.73-
EV/Sales Ratio
1.441.766.358.70-
Asset Turnover
0.510.450.130.09-
Inventory Turnover
3.355.863.26--
Quick Ratio
1.231.272.045.633.57
Current Ratio
1.501.492.316.023.63
Return on Equity (ROE)
-21.87%-30.41%-32.89%-27.35%-
Return on Assets (ROA)
-7.05%-11.04%-14.17%-13.48%-
Return on Capital (ROIC)
-12.50%-17.86%-19.17%-16.30%-
Earnings Yield
-14.33%-19.24%-24.88%-16.92%-
Buyback Yield / Dilution
-20.74%-9.68%-9.68%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.